Previous studies have demonstrated that SH2-containing inositol phosphatase (SHIP) is involved in the control of B cell, myeloid cell and macrophage activation and proliferation. The goal of the present study was to examine the role of SHIP during proliferation and apoptosis in cells of the erythroid lineage. Wild-type and catalytically inactive SHIP proteins were overexpressed in the erythropoietin (EPO)-dependent cell line AS-E2. Stable overexpression of catalytically inactive SHIP decreased proliferation and resulted in prolonged activation of the extracellular signal-regulated protein kinases ERK1/2 and protein kinase B (PKB), while wild-type SHIP did not affect EPOmediated proliferation or phosphorylation of ERK and PKB. When AS-E2 cells were EPO deprived a significant increase in apoptosis was observed in clones overexpressing wild type. Mutational analysis showed that this increase in apoptosis was independent of the enzymatic activity of SHIP. The enhanced apoptosis due to overexpression of SHIP was associated with an increase in caspase-3 and -9 activity, without a distinct effect on caspase-8 activity or mitochondrial depolarization. Moreover, in cells overexpressing SHIP apoptosis could be reduced by a caspase-3 inhibitor. These data demonstrate that in the erythroid cell line AS-E2 overexpression of catalytically inactive SHIP reduced proliferation, while overexpression of wild-type SHIP had no effect. Furthermore, overexpression of SHIP enhanced apoptosis during growth factor deprivation by inducing specific caspase cascades, which are regulated independently of the 5-phosphatase activity of SHIP. Leukemia (2001) 15, 1750-1757.
Introduction
The growth factor erythropoietin (EPO) is crucial for proliferation and differentiation of immature erythroid cells. [1] [2] [3] Binding of EPO to its receptor successively results in receptor dimerization, intracellular tyrosine phosphorylation of the EPO receptor by Janus activating kinases (JAKs) and recruitment of Src homology 2 (SH2) domain containing proteins, including signal transducer and activator of transcription 5 (STAT5), 4 the p85 subunit of phosphoinositide 3-kinase (PI3K) 5, 6 and the SH2 domain-containing inositol 5-phosphatase SHIP.
SHIP is predominantly expressed in cells of the hematopoietic lineage and its predicted amino acid sequence contains an N-terminal SH2 domain, a 5-phosphatase domain, two consensus phosphotyrosine-binding domain motifs and three putative SH3 domain-interacting sites. [7] [8] [9] [10] [11] SHIP has been shown to be tyrosine-phosphorylated in response to cytokine stimulation and to interact with the signalling molecules Shc, Grb2, SHP2 and PI3K. [12] [13] [14] [15] In addition, SHIP binds to tyrosinephosphorylated cytokine and antigen receptors. [16] [17] [18] [19] [20] Its enzymatic activity is selective in dephosphorylating the 5- [7] [8] [9] [10] suggesting an important role for SHIP in the PI3K signalling pathway. This intrinsic 5-phosphatase activity is not increased by tyrosine phosphorylation or interaction with other signalling proteins. It is thought that subcellular relocation of SHIP after receptor stimulation is important to bring SHIP in proximity of its substrate at the plasma membrane. 21 Indeed, it has been demonstrated that SHIP translocates to the actin cytoskeleton in activated platelets. 22 A number of studies have now demonstrated that SHIP performs a negative regulatory role in vivo. SHIP has been implicated in many cellular processes including downregulation of mast cell degranulation, B cell receptor signalling, cytoskeletal rearrangements, cell migration and extracellular calcium influx. 15, 19, 20, [23] [24] [25] Overexpression of SHIP in myeloid cell lines results in decreased cell viability and reduced colony size 9 and induction of apoptosis. 12 SHIP knockout mice show a dramatic chronic hyperplasia of myeloid cells, while the number of late erythroid progenitors is reduced. 26 The signal transduction pathways which are modulated by SHIP appear to involve the protein kinases PKB and ERK1/2, which show prolonged activation in SHIP-deficient B cells and mast cells. 19, [27] [28] [29] So far, little is known about the role of SHIP in erythroid cells especially with regard to proliferation, cell survival or induction of apoptosis. In order to study this in more detail we used overexpression of wild-type SHIP and catalytically inactive SHIP in the EPO-dependent human erythroleukemia cell line AS-E2. 30, 31 While overexpression of SHIP does not affect EPO-dependent proliferation, overexpression of catalytically inactive SHIP significantly decreases proliferation, which might be caused by modulation of PI3K signalling. In the absence of EPO overexpression of SHIP significantly enhanced apoptosis by increasing caspase-9 and caspase-3 activity downstream from mitochondrial depolarization, which is independent of its 5-phosphatase activity.
Materials and methods

Materials
Iscove's modification of Dulbecco's medium with l-glutamine, BSA, pure human transferrin and soybean lecithin (IMDM) was purchased from ICN (Amora, OH, USA) and fetal bovine serum (FBS) from Life Technologies (Rockville, MD, USA). Human recombinant erythropoetin (EPO) was purchased from Cilag (Eprex, Brussels, Belgium) and geneticin (G418) was from Roche Molecular Biochemicals (Mannheim, Germany). Antibodies against ERK1/2 (p44/42 MAPK), PKB(Akt), phospho-S473-PKB, and the monoclonal antibody against phospho-ERK1/2 (Thr202/Tyr204, E10) were purchased from New England Biolabs (Beverly, MA, USA). Anti-body against phosphotyrosine (4G10) was obtained from Upstate Biotechnology (Lake Placid, NY, USA). SHIP antibody was a gift from C Erneux, Interdisciplinary Research Institute, Free University of Brussels, Brussels, Belgium. Antibody against c-myc (9E10), the transfectant agent FuGene, the protease inhibitor cocktail Complete and the TUNEL (terminal deoxynucleotidyltransferase-mediated dUTP-fluorescein nick end labelling) assay kit were purchased from Roche Molecular Biochemicals. The caspase-3 assay kit was purchased from PharMingen (San Diego, CA, USA) and the goat polyclonal antibody against the C-terminus of caspase-3 was obtained from (Santa Cruz Biotechnology, Santa Cruz, CA, USA). The caspase-8 and caspase-9 substrates Ac-IETD-AFC and Ac-LEHD-AFC and the pan-caspase inhibitor t-butoxycarbonylaspartate-fluoromethylketone (Boc-D-fmk) were obtained from Calbiochem (La Jolla, CA, USA).
Cell culture
AS-E2 cells were generously provided by Tomonaga 30 and grown in IMDM supplemented with 20% (v/v) heat-inactivated FBS and 2 U/ml EPO (0.5-1.0 × 10 6 cells/ml if not otherwise stated). For transfected cells this medium was supplemented with 450 g/ml Geneticin (G418). For EPO deprivation experiments cells were prepared by FicollHypaque (Lymphoprep; Nycomed, Oslo, Norway) densitygradient centrifugation to remove cell fragments, washed three times and resuspended in IMDM/FBS/G418 medium (1.0 × 10 6 cells/ml).
Construction of SHIP expression vectors
The expression vectors for wild-type SHIP and catalytically inactive SHIP were generated by a PCR technique and site directed mutagenesis. The PCR technique was used to introduce a myc-tag ahead of the 5′-coding region of human SHIP 7 using primers 5′-ATAAggATCCATggAgCAgAAgCTgATCTCC gAggAggACCTggTCCCCTgCTggAACCAT-3′ and 5′-gTAATAC gACTCACTATAGGG-3′. The PCR product was sequenced, but was found to lack the first 17 bases of the primer. These bases were added by a second PCR using the primers 5′-ATAAggATCCTAAAATggAgCAgAAgCTgATCTCCgAgg-3′ and 5′-AgggCgAATTgggTACCgggC-3′. The resulting Myc-SHIP cDNA sequence was transferred to pcDNA3 expression vector (Invitrogen, Leek, The Netherlands), yielding the expression vector pcDNA3-MycSHIP. Aspartate-672 of MycSHIP was altered into an alanine with the Altered Sites II in vitro mutagenesis system of Promega (Madison, WI, USA) using the Asp672ϾAla672-primer 5′-gCCTTCCTggTgTgCTCgAgTCC TCTgg-3′. The resulting MycSHIP D672A construct was transferred to pcDNA3, yielding the expression vector pcDNA3-MycSHIP D672A . All constructs were sequenced to verify mutations and to exclude any additional mutations due to the procedures. To check the phosphatase activities of MycSHIP and MycSHIP D672A , these proteins were expressed in COS-7 cells using the transfection agent FuGene as described by the manufacturer. The phosphatase activities were measured as described previously, 7,32 using 1 m Ins(1,3,4,5)P 4 as substrate.
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Transfection
Transfection of AS-E2 cells was performed by electroporation. 33 Transfected cells were replated in IMDM/FBS/EPO. After 2 days cells transfected with pcDNA3-MycSHIP, pcDNA3-MycSHIP D672A or pcDNA3 (control cells) were selected in medium supplemented with 450 g/ml Geneticin (G418) using limiting dilution in 96-well plates. Six clones from three independent transfections were found to express MycSHIP construct as identified by Western blotting. Similarly, four MycSHIP D672A expressing clones were obtained from two independent transfections. All experiments were performed with clones obtained from at least two independent transfections.
Western blotting and immunoprecipitation
Cells were lysed in lysis buffer (50 mm Hepes pH 7.4, 100 mm NaF, 4 mm EDTA, 0.5% (w/v) Nonidet P-40, 2 mm Na 3 VO 4 and 1× complete protease inhibitor cocktail. Cell lysates (50 g protein/10 l) were boiled in 1× sample buffer (containing 2% (w/v) SDS, 10% (v/v) glycerol, 100 mm DTT, 0.1% (w/v) bromophenol blue and 50 mm Tris-HCl pH 6.8) and resolved on 7.5% or 12.5% SDS-PAGE gel and transferred to cellulosenitrate membrane (Schleicher & Schuell, Keene, NH, USA). Immunoblotting was performed by standard procedures and detection was performed according to the manufacturer's guidelines (ECL, Amersham, UK). For immunoprecipitation, cell lysates (20 × 10 6 -cells/1 ml lysis buffer) were precleared with protein-A sepharose (Amersham Pharmacia). Subsequently lysates were incubated with 2 l anti-SHIP serum (4 h rotation at 4°C) and rotated for an additional 16 h with 20 l (50% slurry) protein-A sepharose. MycSHIP and MycSHIP D672A were precipitated by 20 h rotating with 5 l (50% slurry) anti-Myc (E10)-agarose conjugate (Santa Cruz Biotechnology). The beads were washed five times with wash buffer (identical to lysis buffer except for the Nonidet P-40 concentration which was 0.1% (w/v)) and analyzed by SDS-PAGE.
Cell proliferation assays
Cell proliferation was assessed with the 3 H-thymidine incorporation assay and cell counting. Cells (5.0 × 10 3 ) were cultured in 150 l medium containing 2 U/ml EPO in 96-well round-bottomed microtiter plates (Greiner, Germany) in triplicate. After 4 days of culture, 6 h prior to cell harvest, 0.1 Ci 3 H-thymidine with a specific activity of 2 Ci/mmol was added to each well.
3 H-thymidine incorporation was determined by liquid scintillation counting. Cells were counted using the trypan-blue dye-exclusion method using a hemocytometer.
Apoptosis assays
Mitochondrial membrane depolarisation was measured using a DioC6 (3,3′-dihexyloxacarbocyanine iodide) assay; 34 EPO deprived cells were harvested, washed in PBS (pH 7.4) and resuspended in PBS containing 25 nm DioC6 (Molecular Probes, Leiden, The Netherlands). After 30 min at 33°C, the cells were washed with PBS and resuspended in PBS containing 1 g/ml propidium iodide. The cells were analyzed by flow cytometry (Calibur; Becton Dickinson, San Jose, CA, USA). In the gate including only the viable propidium iodide negative cells, the percentage of DioC6 negative cells was determined.
DNA fragmentation was measured using a TUNEL procedure based on the manufacturer's instructions. Briefly, cells were EPO deprived, washed twice with 1% (w/v) BSA/PBS, fixed in 2% (w/v) paraformaldehyde/PBS (1 h at room temperature), permeabilized for 5 min in 0.2% (v/v) Tween-20 in PBS at room temperature and labelled with TUNEL reaction mixture (terminal deoxynycleotidyl transferase and nucleotide mixture) for 90 min at 37°C. Cells were analyzed by flow cytometry.
Caspase activity assays
After EPO deprivation the cells were lysed in 10 mm Tris-HCl (pH 7.5), 10 mm NaH 2 PO 4 /NaHPO 4 (pH 7.5), 130 mm NaCl, 1% (v/v) Triton-X-100, 10 mm NaPP i and rapidly frozen in liquid nitrogen. The caspase-3 activity of cell lysates was measured using the caspase-3 assay kit of PharMingen. Briefly, 80 g protein was incubated in 200 l 1× Hepes buffer (supplied in the kit) in the presence of 5 g Ac-DEVD-AMC. After 1 h at 37°C, while the fluorescence was still linearly increasing in time, the fluorescence was measured with a FL600 spectrofluorometer (Becton Dickinson) with excitation and detection wavelengths of 380 (±20) nm and 460 (±40) nm. The fluorescence of cell lysate in Hepes buffer with 0.5 g caspase-3 inhibitor (AC-DEVD-CHO) and 5 g Ac-DEVD-AMC was set as background value. The caspase-8 and -9 activity was measured similarly using 25m Ac-IETD-AFC and Ac-LEHD-AFC, respectively, as substrate and excitation/detection wavelengths of 380(±20) and 545(±40) nm.
To check whether the DNA fragmentation could be blocked by a caspase inhibitor, cells were EPO deprived and cultured for 40 h in the presence of Boc-D-fmk or vehicle (DMSO) and analyzed with the TUNEL assay. To ascertain the inhibitor was present during the period of culturing, fresh t-butoxycarbonylaspartate-fluoromethylketone (Boc-D-fmk, 80 m) or vehicle (DMSO) was added after 0, 18 and 30 h of EPO deprivation. The final DMSO concentration was 0.3%.
Statistical analysis
The Student's t-test for paired samples was used to determine significance of the data.
Results
Overexpression of wild-type and catalytically inactive SHIP in AS-E2 cells
The SHIP protein can influence signal transduction pathways by its interaction with other signalling molecules such as Shc and SHP2, and by its 5-phosphatase activity towards Ins(1,3,4,5)P 4 and PtdIns(3,4,5)P 3 . To examine the role of SHIP and its enzymatic activity in the early erythroid progenitor cell line AS-E2, 28 expression vectors for wild-type (wtSHIP) and catalytically inactive SHIP (SHIP D672A ) were made. As SHIP is endogenously expressed in AS-E2 cells (Figure 1a,  lanes 1 and 2, lower panel) , the expressed SHIP proteins contained a amino-terminal Myc-tag (GE10) to distinguish between endogenous and recombinant SHIP. The expression vector for SHIP D672A was made by replacing aspartate-672 within the conserved 5-phosphatase domain by an alanine residue. As has previously been reported, this mutation resulted in SHIP protein lacking enzymatic activity. 35 Antimyc immunoprecipitates of COS-7 cells expressing wild-type SHIP, mutant SHIP D672A and control (pcDNA3 transfected) cells, hydrolysed Ins(1,3,4,5)P 4 at a rate of 20.0 ± 5.0 mmol/min, 1.5 ± 1.1 mmol/min and 0.2 ± 0.2 mmol/min, respectively.
AS-E2 cells were transfected with control (pcDNA3), wtSHIP or SHIP D672A expression vectors. Clones showing highest levels of wtSHIP or SHIP D672A expression and obtained from at least two independent transfections, were used for further study. The level of overexpressed wtSHIP or SHIP D672A protein was two to three times higher than endogenous SHIP expression (Figure 1a) . Comparable levels of overexpression were found by others overexpressing wild-type SHIP in myeloid cells. 9, 12 As shown in Figure 1b , both wild-type and catalytically inactive SHIP were increasingly tyrosine phosphorylated after EPO stimulation, demonstrating that the EPOdependent signalling routes leading to SHIP phosphorylation are still intact.
Effects of wild-type and catalytically inactive SHIP on proliferation and apoptosis
To study whether the elevated levels of catalytically active or inactive SHIP protein had any effect on EPO-mediated pro-
Figure 2
Effects of SHIP and SHIP D672A overexpression on proliferation and cell survival (a) Three control AS-E2 clones and three independently isolated clones of AS-E2 cells expressing wtSHIP and SHIP D672A were seeded at 0.1 × 10 6 /ml in IMDM/FBS/G418 medium containing 2 U/ml EPO. Trypan-blue-negative cells were counted. Shown are mean ± s. liferation, the growth curves of several different cell lines were investigated. As illustrated in Figure 2a wild-type SHIP expressing cells showed an identical growth curve as control cells, while the growth curve of SHIP D672A overexpressing cells was significantly decreased compared to control cells. The effect of SHIP D672A overexpressing on the growth curves was not caused by a decrease in cell viability during the experiment; after 3 days, the percentage of viable cells of control, wtSHIP and SHIP D672A expressing cells were 92 ± 3%, 90 ± 1% and 86 ± 2%, respectively. The inhibitory effects of SHIP D672A overexpression were also seen on DNA-synthesis as measured with a 3 H-thymidine incorporation assay. As shown in Figure 2b DNA synthesis was 42 ± 5% reduced compared to wild-type SHIP overexpressing and control cells (P Ͻ 0.01).
AS-E2 cells are not only dependent on EPO for their proliferation, but also for their survival. In the absence of EPO AS-E2 cells die by apoptosis. 30 We questioned whether catalytically active or inactive SHIP might affect the survival of EPO deprived AS-E2 cells. As shown in Figure 2c , both wtSHIP and SHIP D672A overexpressing cells died significantly faster than control cells. After 3 days of EPO deprivation 61 ± 4% of wtSHIP overexpressing and 59 ± 5% of SHIP D672A overexpressing cells died, while only 35 ± 5% of control cells died (P Ͻ 0.01). To see if the increased cell death was due to apoptosis, DNA fragmentation was measured by TUNEL (Figure 2d ). After 3 days of EPO deprivation 10 ± 2% of control cells showed DNA fragmentation, while this was increased to 30 ± 2% and 28 ± 3% in wtSHIP overexpressing and SHIP D672A overexpressing cells respectively (mean ± s.d. of three independent experiments, P Ͻ 0.01).
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Overexpression of SHIP D672A results in prolonged ERK/PKB phosphorylation
As the protein kinases PKB and ERK have been implicated in growth factor-mediated proliferation and cell survival, 4, 27, 28, 36 we were interested to see whether overexpression of SHIP had any effect on activation of these proteins. Therefore, we examined the EPO-mediated phosphorylation of these kinases. As shown in Figure 3a and b, ERK and PKB phosphorylation were expressing cells the ERK and PKB phosphorylation were markedly prolonged compared to control and wild-type SHIP overexpressing cells.
To investigate if the ERK and PKB pathways are involved in proliferation, we pre-treated the cells for 30 min with the specific MEK inhibitor PD098059 or the specific PI3K inhibitor LY294002. Using 10 m PD098059 almost complete inhibition of ERK phosphorylation was observed, while proliferation was only 14 ± 4% reduced (Figure 4a and b) , indicating that inhibition of nearly all ERK, does not block proliferation. As shown in Figure 4c and d, cells treated with LY294002 showed decreased PKB phosphorylation and decreased proliferation. This indicates proliferation is dependent on PI3K activity. Interestingly, the proliferation of SHIP D672A expressing cells was significantly more sensitive towards LY294002 compared to the proliferation of wild-type SHIP and control clones.
Apoptosis by EPO deprivation
In view of the increase in DNA fragmentation observed in wtSHIP and SHIP D672A overexpressing cells after EPO deprivation, we studied in more detail the processes involved in apoptosis, including loss of mitochondrial membrane potential and activation of caspases. Using the tetra-peptide Ac-DEVD-AMC as substrate, wtSHIP and SHIP D672A overexpressing cells showed 70 ± 7% more caspase-3 activity after 1 day EPO deprivation than control cells (P Ͻ 0.001; Figure 5a ). This was confirmed by immunoblotting (Figure 5b ). Inactive procaspase-3 was present when cells were exponentially growing. However, when cells were EPO deprived, cleavage of procaspase-3 to its active form could be observed by the formation of p11 product. Both wild-type overexpressing and catalytically inactive SHIP cells showed significantly more p11 product than control cells. Taken together, the data indicate that SHIP increases caspase-3 activity and apoptosis independently from its enzymatic activity.
SHIP increases caspase-3 and caspase-9 activity
To further define the pathways involved in the increased caspase-3 activity, the activities of caspase-8 and -9 were measured in control and SHIP overexpressing cells (Figure 6b and  c) . As control for caspase-8 activation AS-E2 cells were cul-
Figure 4
Proliferation correlates with PKB phosphorylation and is independent of full ERK phosphorylation. tured with interferon ␥ to induce Fas receptor expression. 37 Subsequent Fas stimulation resulted in a five-fold increase of caspase-8 activity. In contrast, EPO deprivation of the control cells resulted in only a two-fold increase in caspase-8 activity, which was not further augmented by wtSHIP overexpression (Figure 6b ). Caspase-9 activity on the other hand showed a three-to four-fold increase after EPO deprivation, while wtSHIP overexpression resulted in an even higher caspase-9
Figure 5
The increased apoptosis is independent of the 5-phosphatase activity of SHIP. (a) The caspase-3 activity after 1 day of EPO deprivation was measured using the tetra-peptide substrate Ac-DEVD-AMC and expressed in arbitrary fluorescence units (A.U.) (mean ± s.d. of two independent experiments with 2 clones. * = P Ͻ 0.01 compared to control cells) (b) The same cell lysates (t = 1 −EPO) and cell lysates of cells which were not EPO deprived (t = 0) were subjected to Western blotting with the caspase-3 (K19) antibody recognizing the pro-caspase and the p11 slice product (p11). A representative blot from two independent experiments is shown. activity (175% of control, P Ͻ 0.001, Figure 6c ). Since caspase-9 can be activated after mitochondrial membrane depolarization, we tested whether wtSHIP overexpression also affected the membrane potential (Figure 6d) . A time-dependent increase in the membrane depolarization was observed, but no significant difference was found between wtSHIP overexpressing clones and control clones.
Finally, to demonstrate that caspases are involved in the apoptotic process in response to EPO deprivation, we incubated the wtSHIP overexpressing clone MS1 in the absence and presence of the pan caspase inhibitor t-butoxycarbonylaspartate-fluoromethylketone (Boc-D-fmk). Treatment of the cells with vehicle (DMSO), during 2 days EPO deprivation resulted in 14 ± 2% of cells showing DNA fragmentation as measured by TUNEL assay, while incubation with Boc-D-fmk resulted in significantly less apoptotic cells, only 7 ± 1% of Boc-D-fmk-treated cells were TUNEL positive (P Ͻ 0.01).
Discussion
In the present study we investigated the effects of overexpressing wild-type and catalytically inactive SHIP during EPO stimulation and growth factor deprivation in cells of the erythroid lineage. In the presence of EPO, overexpression of wild-type SHIP had no effect on proliferation, while overexpression of catalytically inactive SHIP significantly decreased proliferation, suggesting that blockage of the 5-phosphatase activity of SHIP reduces proliferation. Recent experiments by others have indicated a role for SHIP in differ-
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Figure 6
SHIP overexpression increases apoptosis downstream from mitochondrial depolarization. Whole cell lysates of EPO deprived cells were analyzed for (a) caspase-3 activity (n = 3), (b) caspase-8 activity (n = 2) and (c) caspase-9 activity (n = 3). entiation, besides proliferation. Transplantation studies with SHIP-deficient cells into lethally irradiated recipients showed that SHIP-deficient cells differentiate faster than wild-type cells, suggesting that SHIP blocks differentiation. 38 Overexpression of catalytically inactive SHIP D672A in AS-E2 cells might reduce proliferation by induction of differentiation. Of interest is also the finding that expressing SHIP in K562 cells inhibits hemin-induced hemoglobin synthesis, suggesting a role for SHIP in erythroid differentiation. 39 The prolonged ERK phosphorylation in SHIP D672A expressing sells supports this hypothesis, since prolonged ERK activation drives cells into differentiation. 40 However, we were not able to induce differentiation and investigate the effects of SHIP in AS-E2 cells.
In the absence of EPO, both wild-type and catalytically inactive SHIP overexpressing cells showed increased programmed cell death, compared to control cells. This could mean that SHIP regulates apoptosis independently of PtdIns(3,4,5)P 3 levels in these erythroid cells or alternatively that both wild-type and phosphatase dead SHIP might disrupt the 'normal' activity of SHIP in keeping the levels of PI3K lipid products balanced. The latter option assumes that the catalytically inactive SHIP is acting in a dominant negative fashion and would indicate that either lower or higher SHIP activity is harmful to cells. The increase in apoptosis is comparable with a negative regulatory role of SHIP in apoptosis found in mast cells and neutrophils from SHIP-deficient mice, which have been shown to display enhanced resistance to apoptosis following serum and growth factor withdrawal. 27 Myeloid cells of SHIP-deficient mice showed increased proliferation, which was associated with increased PKB phosphorylation and elevated PtdIns(3,4,5)P 3 levels. 27 As PKB can contribute to cell survival, the prolonged PKB phosphorylation could explain the observed increase in myeloid proliferation. In our studies the PI3K inhibitor LY294002 also blocked proliferation. Remarkably, SHIP D672A overexpressing AS-E2 cells exhibit prolonged PKB activation, but a decreased proliferation. This could be due to an inbalance of PtdIns(3,4,5)P 3 levels or dominant negative effects of SHIP D672A as suggested above. Furthermore, SHIP D672A expressing cells are more sensitive to the PI3K inhibitor LY294002 than wtSHIP overexpressing cells.
Overexpression of SHIP in the absence of EPO was associated with an increase in activity of caspase-3 and -9 without a distinct change in the caspase-8 activity. However, the exact link between programmed cell death and SHIP is not well defined. During the apoptotic process, mitochondria release apoptogenic molecules to activate the downstream apoptotic signal transduction pathways, including apoptosis inducing factor (AIF) and cytochrome c. 41 Besides these signalling routes Bcl-X L might interfere with the mitochondrial function. However, no distinct differences in membrane depolarization or Bcl-X L protein expression (data not shown) were observed between control and SHIP overexpressing cells. Therefore, SHIP appears to interact with the caspase-9 and caspase-3 apoptotic pathway downstream from mitochondrial depolarization.
Since the increased apoptosis of SHIP overexpressing cells was not caused by the 5-phosphatase activity of SHIP, other regulatory domains appear to be involved in this process, like the noncatalytic C-terminal proline-rich region or the N-terminal SH2 domain which were found to be essential for the inhibitory signalling of B cells and the increased apoptosis observed in DA-ER cells, respectively. 12, 42 Future experiments will show which protein interactions are involved in SHIPmediated increase of apoptosis and which proliferative pathways are affected by modulation of phosphatidyl inositol levels.
